Home

About Us

Contact Us

Articles

News

Links

Nasa is awarding Regenetech, Inc. admision to the Space Hall of Fame based on its development of therapeutics involving adult stem cells and its development of  a policy of wide range of patent applications based on NASA technology. The therapeutic applications were invented by Dr. Rudd and he single handedly developed the patent strategy based on it.

NASA
NASA AWARDING
Space Technology Hall of Fame AWARD
TO REGENETECH
BASED ON RESEARCH DEVELOPED ESSENTIALLY

The healing properties of the Magnavet unit follow research conducted by NASA, Dr. Rudd, and Dr. Dennis. Dr. David Wolf (M.D., electrical engineer, astronaut), Dr. Robert Dennis, Professor at University of North Carolina, Chappel Hill, and Dr. Donnie Rudd, former Chief Scientist of a biotech company, are the inventors.
 Research originally began at NASA for the purpose of expanding adult (not embryonic) stem cells. On earth, attempts to expand stem cells in a flask were unsuccessful because the cells are adherent and will stick to the sides of the flask and die.
Since the research was being sponsored at NASA, the inventors devised a test to see if the cells would expand (grow) better in space, on a shuttle flight, in near zero gravity so they would float and not adhere to the sides of the container. The test was very successful.
The inventors then looked at ways to duplicate the results on earth. The result was a rotating bioreactor that rotated in a manner that kept the cells in the center of a rotating container and simulated zero gravity so the cells would not touch the sides of the container.

Method of regenerating human tissue

Method of replenishing cells damaged  by treatment for cancer

Method of repairing primate mammalian tissue
Method of regenerating human tissue

Method of repairing primate mammalian tissue

Method of providing readily available cellular material derived from cord blood, and a composition thereof

Method and composition for repairing epithelial and other cells and tissue

Method and composition for treating diabetes

Natively glycosylated mammalian biological molecules produced by electromagnetically stimulating living mammalian cells

ROTATABLE TIME VARYING ELECTROMAGNETIC FORCE BIOREACTOR AND METHOD OF USING THE SAME

METHOD OF PROVIDING READILY AVAILABLE CELLULAR MATERIAL DERIVED FROM PERIPHERAL BLOOD

PROCESS FOR PREPARING BONE MARROW STEM CELLS, AND COMPOSITION RELATED THERETO

METHOD OF PROVIDING READILY AVAILABLE CELLULAR MATERIAL DERIVED FROM PERIPHERA BLOOD, AND A COMPOSITOIN THEREO

@Copyright 2011.Ming's World. All Right Reserved.
The Magnavet is NOT FOR HUMAN USE. The MagnaVet device is intended to safely and effectively promote healing in hard and soft tissue injury and chronic disease states, including, but not limited to, long bone fracture, tendon, ligament, and cartilage injury, and osteoarthritis in pets. It is only available by prescription from a qualified veterinarian, and is expressly not intended to treat food or food-producing animals.